These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2542665)

  • 21. Prevention of shingles by varicella zoster virus vaccination.
    Holodniy M
    Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and quality control of the Oka-strain live varicella vaccine.
    D'Hondt E; Berge E; Colinet G; Duchene M; Peetermans J
    Postgrad Med J; 1985; 61 Suppl 4():53-6. PubMed ID: 3014478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and characterization of a live varicella vaccine (Oka strain).
    Takahashi M
    Biken J; 1984 Sep; 27(2-3):31-6. PubMed ID: 6100054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
    Levin MJ; Smith JG; Kaufhold RM; Barber D; Hayward AR; Chan CY; Chan IS; Li DJ; Wang W; Keller PM; Shaw A; Silber JL; Schlienger K; Chalikonda I; Vessey SJ; Caulfield MJ
    J Infect Dis; 2003 Nov; 188(9):1336-44. PubMed ID: 14593591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical use of Oka live varicella vaccine.
    Kamiya H; Sakurai M; Ihara T; Ito M; Torigoe S; Ota Y; Kamiya T; Horiuchi K; Asano Y; Baba K
    Acta Paediatr Jpn; 1988 Oct; 30(5):594-600. PubMed ID: 2849859
    [No Abstract]   [Full Text] [Related]  

  • 26. Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka).
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):123-8. PubMed ID: 6100049
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia].
    MMW Fortschr Med; 2006; Spec no.1():14-5. PubMed ID: 16872127
    [No Abstract]   [Full Text] [Related]  

  • 28. [Does vaccination for chickenpox prevent herpes zoster? (interview by Waldtraut Paukstadt)].
    Doerr HW
    MMW Fortschr Med; 2002 Dec; 144(50):12. PubMed ID: 14610859
    [No Abstract]   [Full Text] [Related]  

  • 29. Varicella vaccine: still at the crossroads.
    Gershon AA
    Pediatrics; 1992 Jul; 90(1 Pt 2):144-8. PubMed ID: 1318541
    [No Abstract]   [Full Text] [Related]  

  • 30. A live varicella vaccine in a pediatric community.
    Yabuuchi H; Baba K; Tsuda N; Okada S; Nose O; Seino Y; Tomita K; Ha K; Mimaki T; Ogawa M
    Biken J; 1984 Sep; 27(2-3):43-9. PubMed ID: 6100057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract]   [Full Text] [Related]  

  • 32. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
    Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
    Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
    Chiba Y; Miura J; Kumagai T; Nakao T
    Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chickenpox vaccination of healthy children: immunological and clinical responses and protective effect in 1978-1982.
    Horiuchi K
    Biken J; 1984 Sep; 27(2-3):37-8. PubMed ID: 6100055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral and cellular immune response to varicella-zoster virus in children inoculated with live attenuated varicella vaccine.
    Kumagai T; Chiba Y; Fujiwara M; Hanazono H; Nakamura S; Chiba S; Nakao T; Takahashi M
    Biken J; 1980 Sep; 23(3):135-41. PubMed ID: 6257227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
    Diaz PS; Au D; Smith S; Amylon M; Link M; Smith S; Arvin AM
    Pediatrics; 1991 Feb; 87(2):166-70. PubMed ID: 1846236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells.
    Levy O; Orange JS; Hibberd P; Steinberg S; LaRussa P; Weinberg A; Wilson SB; Shaulov A; Fleisher G; Geha RS; Bonilla FA; Exley M
    J Infect Dis; 2003 Oct; 188(7):948-53. PubMed ID: 14513412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect and follow-up study on varicella vaccine.
    Katsushima N; Yazaki N; Sakamoto M
    Biken J; 1984 Sep; 27(2-3):51-8. PubMed ID: 6100058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varicella vaccine studies in healthy children and adults.
    Arbeter AM; Starr SE; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):748-56. PubMed ID: 3020494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.